发明申请
- 专利标题： Antagonists of the bradykinin B1 receptor
- 专利标题（中）： 缓激肽B1受体的拮抗剂
-
申请号： US10972236申请日： 2004-10-21
-
公开(公告)号： US20050215470A1公开(公告)日： 2005-09-29
- 发明人: Gordon Ng , Yue-Sheng Li , Colin Gegg , Benny Askew , Thomas Storz , Yuelie Lu , Derin D'Amico
- 申请人： Gordon Ng , Yue-Sheng Li , Colin Gegg , Benny Askew , Thomas Storz , Yuelie Lu , Derin D'Amico
- 专利权人： Amgen Inc.
- 当前专利权人： Amgen Inc.
- 主分类号： A61K38/08
- IPC分类号： A61K38/08 ; A61K38/10 ; A61K47/48 ; A61P29/00 ; C07K7/06 ; C07K7/08 ; C07K7/18
摘要：
The present invention relates to certain biologically active peptides and conjugated peptides which can be used as therapeutics or prophylactics against diseases or conditions linked to B1 as the causative agent. In a preferred embodiment of the invention biologically active PEG-conjugated peptides are provided. In one aspect of the present invention, pharmacologically active PEG-conjugated peptides of the present invention are useful to treat inflammation or pain.
公开/授权文献
- US07605120B2 Antagonists of the brandykinin B1 receptor 公开/授权日：2009-10-20
信息查询
IPC分类:
